What is ClearlyDerm?
ClearlyDerm operates as a premier dermatology provider, delivering a comprehensive suite of medical, surgical, pediatric, and cosmetic skin care solutions. The organization distinguishes itself through a team of board-certified dermatologists who manage complex conditions ranging from chronic acne and dermatological rashes to the surgical management of skin cancer. Beyond standard clinical care, the company maintains a strong market presence by integrating advanced cosmetic procedures, such as injectables and chemical peels, with a proprietary product line. Furthermore, ClearlyDerm serves as a critical hub for clinical research, providing patients with early access to innovative treatment modalities and therapeutic breakthroughs in skin health.
How much funding has ClearlyDerm raised?
ClearlyDerm has raised a total of $1M across 2 funding rounds:
Debt
$150K
Debt
$863K
Debt (2020): $150K with participation from PPP
Debt (2021): $863K led by PPP
Key Investors in ClearlyDerm
PPP
Public-Private Partnership
What's next for ClearlyDerm?
With the recent infusion of capital, ClearlyDerm is poised to accelerate its growth trajectory through both organic expansion and the enhancement of its clinical trial infrastructure. The firm is expected to prioritize the integration of advanced medical technologies to streamline patient outcomes while potentially expanding its geographic reach beyond its current South Florida stronghold. As the company transitions into this next phase of enterprise-level development, the focus will likely remain on maintaining high-quality care standards while scaling its cosmetic and surgical service lines to meet the rising demand for specialized dermatological interventions.
See full ClearlyDerm company page
